Vaxart (VXRT) Stock Statistics & Valuation Metrics

Vaxart has a market cap or net worth of $92.53M. The enterprise value is $80.66M.

Vaxart has 228,310,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vaxart’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -81.49%.

The current PE Ratio of Vaxart is -19.99. Vaxart’s PEG ratio is <0.01.

In the last 12 months, Vaxart had revenue of 28.70M and earned -66.95M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -33.17M and capital expenditures -553.00K, giving a free cash flow of -33.73M billion.

Vaxart pays an annual dividend of $12.188, resulting in a dividend yield of ―

Vaxart upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

Vaxart as a current ratio of 0.75, with Debt / Equity ratio of 36.89%

In the past 12 months, Vaxart has paid 260.00K in taxes.

Vaxart EV to EBITDA ratio is -22.43, with an EV/FCF ratio of -29.36.

Vaxart has $41.94M in cash and marketable securities with $16.83M in debt, giving a net cash position of -$25.11M billion.

Gross margin is 16.75%, with operating margin of -230.99%, and net profit margin of -233.27%.

The average price target for Vaxart is $2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy